Literature DB >> 12756142

Adult polyglucosan body disease associated with lewy bodies and tremor.

Jaya R Trivedi1, Gil I Wolfe, Sharon P Nations, Dennis K Burns, Wilson W Bryan, Richard B Dewey.   

Abstract

BACKGROUND: Adult polyglucosan body disease (PGBD) is rare and typically presents with upper and lower motor neuron involvement and neurogenic bladder. Extrapyramidal features are unusual in PGBD and are presumed secondary to widespread pathology that includes the basal ganglia. There are no prior reports of Lewy bodies in PGBD.
OBJECTIVE: To report a unique finding of Lewy bodies in a patient with PGBD. REPORT OF A CASE A 46-year-old woman initially presented with a 4-year history of resting tremor. The tremor responded to levodopa therapy. Several months later, she developed upper and lower motor neuron involvement and other clinical features of PGBD. A sural nerve biopsy specimen revealed intra-axonal polyglucosan bodies that confirmed the clinical diagnosis. Bulbar and limb weakness progressed, and she developed dementia. She died 6 years after onset. At autopsy, extensive polyglucosan body formation was found in many regions of the central nervous system. In addition, numerous alpha-synuclein staining Lewy bodies were observed in the substantia nigra, accompanied by marked neuron depopulation.
CONCLUSIONS: To our knowledge, this is the first report of adult PGBD associated with Lewy bodies and levodopa-responsive tremor. Although polyglucosan bodies were seen in substantia nigra, it is most likely that our patient had coexisting Parkinson disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12756142     DOI: 10.1001/archneur.60.5.764

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  7 in total

1.  A case of adult polyglucosan body disease.

Authors:  Seung-Yeob Lee; Jae-Hyeon Park; So Hun Kim; Tai-Seung Kim; Won-Joo Kim; Young-Chul Choi
Journal:  Yonsei Med J       Date:  2007-08-31       Impact factor: 2.759

Review 2.  Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: a diagnostic approach.

Authors:  F Sedel; B Fontaine; J M Saudubray; O Lyon-Caen
Journal:  J Inherit Metab Dis       Date:  2007-10-22       Impact factor: 4.982

3.  ALS-Plus syndrome: non-pyramidal features in a large ALS cohort.

Authors:  Leo McCluskey; Shannon Vandriel; Lauren Elman; Vivianna M Van Deerlin; John Powers; Ashley Boller; Elisabeth McCarty Wood; John Woo; Corey T McMillan; Katya Rascovsky; Murray Grossman
Journal:  J Neurol Sci       Date:  2014-07-18       Impact factor: 3.181

4.  Glycogen synthase protects neurons from cytotoxicity of mutant huntingtin by enhancing the autophagy flux.

Authors:  Anupama Rai; Pankaj Kumar Singh; Virender Singh; Vipendra Kumar; Rohit Mishra; Ashwani Kumar Thakur; Anita Mahadevan; Susarla Krishna Shankar; Nihar Ranjan Jana; Subramaniam Ganesh
Journal:  Cell Death Dis       Date:  2018-02-08       Impact factor: 8.469

5.  Cerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organelles.

Authors:  Paula P Navarro; Christel Genoud; Daniel Castaño-Díez; Alexandra Graff-Meyer; Amanda J Lewis; Yvonne de Gier; Matthias E Lauer; Markus Britschgi; Bernd Bohrmann; Stephan Frank; Jürgen Hench; Gabriel Schweighauser; Annemieke J M Rozemuller; Wilma D J van de Berg; Henning Stahlberg; Sarah H Shahmoradian
Journal:  Sci Rep       Date:  2018-12-21       Impact factor: 4.379

Review 6.  Movement disorders and inborn errors of metabolism in adults: a diagnostic approach.

Authors:  F Sedel; J-M Saudubray; E Roze; Y Agid; M Vidailhet
Journal:  J Inherit Metab Dis       Date:  2008-05-30       Impact factor: 4.750

7.  Neuronal glycogen synthesis contributes to physiological aging.

Authors:  Christopher Sinadinos; Jordi Valles-Ortega; Laura Boulan; Estel Solsona; Maria F Tevy; Mercedes Marquez; Jordi Duran; Carmen Lopez-Iglesias; Joaquim Calbó; Ester Blasco; Marti Pumarola; Marco Milán; Joan J Guinovart
Journal:  Aging Cell       Date:  2014-07-25       Impact factor: 9.304

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.